Urinary granzyme A mRNA is a biomarker to diagnose subclinical and acute cellular rejection in kidney transplant recipients

Kidney International

Volumn 78, Issue 10, 2010, Pages 1033-1040

  Van Ham, S Marieke ^a   Heutinck, Kirstin M ^b,c   Jorritsma, Tineke ^a   Bemelman, Fréderike J ^c   Strik, Merel C M ^a   Vos, Wim ^d   Muris, Jettie J F ^d   Florquin, Sandrine ^b   Ten Berge, Ineke J M ^c   Rowshani, Ajda T ^c,e  

^a SANQUIN RESEARCH   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c Division of Nephrology   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

acute rejection; granzyme A; granzyme B; kidney transplantation; non invasive biomarker; subclinical rejection

Indexed keywords

GRANZYME A; GRANZYME B; MESSENGER RNA; PERFORIN;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; AGED; ARTICLE; CELL INFILTRATION; COHORT ANALYSIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; FEMALE; GRAFT RECIPIENT; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE NECROSIS; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SENSITIVITY AND SPECIFICITY; T LYMPHOCYTE; URINALYSIS;

EID: 78049479779     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2010.274     Document Type: Article

References (36)

1. Choi BS, Shin MJ, Shin SJ et al. Clinical significance of an early protocol biopsy in living-donor renal transplantation: ten-year experience at a single center. Am J Transplant 2005; 5: 1354-1360.
2. Opelz G, Dohler B. Influence of time of rejection on long-term graft survival in renal transplantation. Transplantation 2008; 85: 661-666.
3. Nankivell BJ, Borrows RJ, Fung CL et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
4. Nankivell BJ, Borrows RJ, Fung CL et al. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation 2004; 78: 242-249.
5. Moreso F, Ibernon M, Goma M et al. Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss. Am J Transplant 2006; 6: 747-752.
6. Shishido S, Asanuma H, Nakai H et al. The impact of repeated subclinical acute rejection on the progression of chronic allograft nephropathy. J Am Soc Nephrol 2003; 14: 1046-1052.
7. Kee TY, Chapman JR, O'Connell PJ et al. Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants. Transplantation 2006; 82: 36-42.
8. Rush D, Nickerson P, Gough J et al. Beneficial effects of treatment of early subclinical rejection: a randomized study. J Am Soc Nephrol 1998; 9: 2129-2134.
9. Rush D, Arlen D, Boucher A et al. Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study. Am J Transplant 2007; 7: 2538-2545.
10. Seron D, Moreso F. Protocol biopsies in renal transplantation: prognostic value of structural monitoring. Kidney Int 2007; 72: 690-697.
11. Wilkinson A. Protocol transplant biopsies: are they really needed? Clin J Am Soc Nephrol 2006; 1: 130-137.
12. Anglicheau D, Suthanthiran M. Noninvasive prediction of organ graft rejection and outcome using gene expression patterns. Transplantation 2008; 86: 192-199.
13. Kummer JA, Wever PC, Kamp AM et al. Expression of granzyme A and B proteins by cytotoxic lymphocytes involved in acute renal allograft rejection. Kidney Int 1995; 47: 70-77.
14. Aquino-Dias EC, Joelsons G, da Silva DM et al. Non-invasive diagnosis of acute rejection in kidney transplants with delayed graft function. Kidney Int 2008.
15. Yannaraki M, Rebibou JM, Ducloux D et al. Urinary cytotoxic molecular markers for a noninvasive diagnosis in acute renal transplant rejection. Transpl Int 2006; 19: 759-768.
16. Li B, Hartono C, Ding R et al. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine. N Engl J Med 2001; 344: 947-954.
17. Chowdhury D, Lieberman J. Death by a thousand cuts: granzyme pathways of programmed cell death. Annu Rev Immunol 2008; 26: 389-420.
18. Froelich CJ, Pardo J, Simon MM. Granule-associated serine proteases: granzymes might not just be killer proteases. Trends Immunol 2009.
19. Metkar SS, Menaa C, Pardo J et al. Human and mouse granzyme a induce a proinflammatory cytokine response. Immunity 2008; 29: 720-733.
20. Trapani JA, Bird PI. A renaissance in understanding the multiple and diverse functions of granzymes? Immunity 2008; 29: 665-667.
21. Rowshani AT, Florquin S, Bemelman F et al. Hyperexpression of the granzyme B inhibitor PI-9 in human renal allografts: a potential mechanism for stable renal function in patients with subclinical rejection. Kidney Int 2004; 66: 1417-1422.
22. Dadhania D, Muthukumar T, Ding R et al. Molecular signatures of urinary cells distinguish acute rejection of renal allografts from urinary tract infection. Transplantation 2003; 75: 1752-1754.
23. Muthukumar T, Ding R, Dadhania D et al. Serine proteinase inhibitor-9, an endogenous blocker of granzyme B/perforin lytic pathway, is hyperexpressed during acute rejection of renal allografts. Transplantation 2003; 75: 1565-1570.
24. Rush DN, Henry SF, Jeffery JR et al. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57: 208-211.
25. Schaub S, Nickerson P, Rush D et al. Urinary CXCL9 and CXCL10 levels correlate with the extent of subclinical tubulitis. Am J Transplant 2009; 9: 1347-1353.
26. Schaub S, Mayr M, Honger G et al. Detection of subclinical tubular injury after renal transplantation: comparison of urine protein analysis with allograft histopathology. Transplantation 2007; 84: 104-112.
27. Peng W, Chen J, Jiang Y et al. Prediction of subclinical renal allograft rejection by vascular endothelial growth factor in serum and urine. J Nephrol 2008; 21: 535-542.
28. Matz M, Beyer J, Wunsch D et al. Early post-transplant urinary IP-10 expression after kidney transplantation is predictive of short-and long-term graft function. Kidney Int 2006; 69: 1683-1690.
29. Alakulppi NS, Kyllonen LE, Partanen J et al. Diagnosis of acute renal allograft rejection by analyzing whole blood mRNA expression of lymphocyte marker molecules. Transplantation 2007; 83: 791-798.
30. Simon T, Opelz G, Wiesel M et al. Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients. Am J Transplant 2003; 3: 1121-1127.
31. Chattopadhyay PK, Betts MR, Price DA et al. The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression. J Leukoc Biol 2009; 85: 88-97.
32. van Leeuwen EM, de Bree GJ, ten Berge IJM et al. Human virus-specific CD8+ T cells: diversity specialists. Immunol Rev 2006; 211: 225-235.
33. Rowshani AT, Strik MC, Molenaar R et al. The granzyme B inhibitor SERPINB9 (protease inhibitor 9) circulates in blood and increases on primary cytomegalovirus infection after renal transplantation. J Infect Dis 2005; 192: 1908-1911.
34. Solez K, Colvin RB, Racusen LC et al. Banff '05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-526.
35. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
36. Myers GL, Miller WG, Coresh J et al. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem 2006; 52: 5-18.